The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Fludarabine Phosphate
Fludarabine Phosphate · FLUDARABINE PHOSPHATE 25 mg/mL · Injection, Solution · Intravenous · Sagent Pharmaceuticals
NDC 25021-0242-02 · 1 VIAL in 1 CARTON / 2 mL in 1 VIAL · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$217.50
Reported to Texas DSHS · 2026 annual filing · Sagent Pharmaceuticals
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 50 MG
$206.299
HCPCS J9185 · Jul 1, 2026 quarter · typically ASP + 6%
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA076661
- TE code
- AP1
- Approval date
- Apr 28, 2004
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Fludarabine Phosphate (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Hisun Pharmaceuticals USA, Inc. | FLUDARABINE PHOSPHATE 25 mg/mL | Sep 3, 2026 | Sep 3, 2026 |
| Fresenius Kabi USA, LLC | FLUDARABINE PHOSPHATE 25 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | FLUDARABINE PHOSPHATE 25 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Fludarabine Phosphate — NDC 25021-0242-02," retrieved September 3, 2026, https://drugdashboards.com/drug/25021024202.
Free to cite with attribution — see how the data is put together.